Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Debt Ratio: 2019-2025

Historic Debt Ratio for Ascendis Pharma A (ASND) over the last 5 years, with Sep 2025 value amounting to 91,888,898.85.

  • Ascendis Pharma A's Debt Ratio rose 11.16% to 91,888,898.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 389,727,560.28, marking a year-over-year decrease of 1.15%. This contributed to the annual value of 0.70 for FY2024, which is 8.54% down from last year.
  • Latest data reveals that Ascendis Pharma A reported Debt Ratio of 91,888,898.85 as of Q3 2025, which was down 13.38% from 106,084,989.13 recorded in Q2 2025.
  • In the past 5 years, Ascendis Pharma A's Debt Ratio ranged from a high of 141,077,904.89 in Q1 2023 and a low of 0.10 during Q4 2021.
  • Its 3-year average for Debt Ratio is 89,602,609.02, with a median of 102,689,447.54 in 2024.
  • Per our database at Business Quant, Ascendis Pharma A's Debt Ratio crashed by 100.00% in 2021 and then surged by 278.64% in 2022.
  • Quarterly analysis of 5 years shows Ascendis Pharma A's Debt Ratio stood at 0.10 in 2021, then spiked by 278.64% to 0.37 in 2022, then soared by 108.35% to 0.76 in 2023, then declined by 8.54% to 0.70 in 2024, then increased by 11.16% to 91,888,898.85 in 2025.
  • Its Debt Ratio stands at 91,888,898.85 for Q3 2025, versus 106,084,989.13 for Q2 2025 and 88,747,491.21 for Q1 2025.